首页> 美国卫生研究院文献>Intractable Rare Diseases Research >Reporting one very rare pathogenic variation c.1106GA in POMT2 gene
【2h】

Reporting one very rare pathogenic variation c.1106GA in POMT2 gene

机译:报告POMT2基因中一种非常罕见的致病性变异c.1106G A

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Dystroglycan (DG) is a major cell membrane glycoprotein, which is encoded by the gene. α-DG is one of DG subunits, belongs to O-mannosylated protein of mammals and was identified in brain, peripheral nerves and muscle. Dystroglycanopathies are a group of heterogeneous congenital muscular dystrophies, which can result from defective α-DG mannosylation. First line of α-DG glycosylation is catalyzed by protein O-mannosyltransferase family (PMT). In this study, the mutation was identified in the gene, which encodes O-mannosyltransferase 2 protein and its mutations can be contributed to dystroglycanopathies. A very rare missense mutation in the gene ( : exon9: c. 1106G>A) was identified by next generation sequencing (NGS) and was subsequently confirmed using Sanger sequencing in both affected siblings. There was no report of this mutation in the literature, therefore, the significance was uncertain. Our findings confirmed the pathogenicity of mutation and expanded the mutation spectrum of , which will be helpful in further molecular evaluations of muscular diseases.
机译:dystroglycan(DG)是主要的细胞膜糖蛋白,由该基因编码。 α-DG是DG亚基之一,属于哺乳动物的O-甘露糖基化蛋白,已在大脑,周围神经和肌肉中发现。营养不良性糖异常是一组先天性异型肌营养不良,可能是由α-DG甘露糖基化缺陷引起的。 α-DG糖基化的第一线由蛋白O-甘露糖基转移酶家族(PMT)催化。在这项研究中,在编码O-甘露糖基转移酶2蛋白的基因中鉴定出突变,其突变可导致营养不良性糖病。通过下一代测序(NGS)鉴定出该基因中非常罕见的错义突变(:exon9:c。1106G> A),随后在两个受影响的兄弟姐妹中使用Sanger测序对其进行了确认。在文献中没有关于这种突变的报道,因此,其意义尚不确定。我们的发现证实了突变的致病性并扩大了的突变谱,这将有助于进一步对肌肉疾病进行分子评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号